Indication

Obstruction

1 clinical trial

1 product

Clinical trial

Camrelizumab Combined With Neoadjuvant Chemotherapy After Stent Placement Versus Surgery Alone for Left-Sided Obstructive Colonic Cancer

Status: Recruiting, Estimated PCD: 2023-12-30

Product